Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
04 01 2022
Historique:
entrez: 5 1 2022
pubmed: 6 1 2022
medline: 26 2 2022
Statut: epublish

Résumé

Transient ischemic attack (TIA) often indicates a high risk of subsequent cerebral ischemic events. Timely preventive measures improve the outcome. To estimate and compare the risk of subsequent ischemic stroke among patients with TIA or minor ischemic stroke (mIS) by care setting. MEDLINE, Web of Science, Scopus, Embase, International Clinical Trials Registry Platform, ClinicalTrials.gov, Trip Medical Database, CINAHL, and all Evidence-Based Medicine review series were searched from the inception of each database until October 1, 2020. Studies evaluating the occurrence of ischemic stroke after TIA or mIS were included. Cohorts without data on evaluation time for reporting subsequent stroke, with retrospective diagnosis of the index event after stroke occurrence, and with a report of outcomes that were not limited to patients with TIA or mIS were excluded. Two authors independently screened the titles and abstracts and provided the list of candidate studies for full-text review; discrepancies and disagreements in all steps of the review were addressed by input from a third reviewer. The study was prepared and reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses, Meta-analysis of Observational Studies in Epidemiology, Methodological Expectations of Cochrane Intervention Reviews, and Enhancing the Quality and Transparency of Health Research guidelines. The Risk of Bias in Nonrandomized Studies-of Exposures (ROBINS-E) tool was used for critical appraisal of cohorts, and funnel plots, Begg-Mazumdar rank correlation, Kendall τ2, and the Egger bias test were used for evaluating the publication bias. All meta-analyses were conducted under random-effects models. Risk of subsequent ischemic stroke among patients with TIA or mIS who received care at rapid-access TIA or neurology clinics, inpatient units, emergency departments (EDs), and unspecified or multiple settings within 4 evaluation intervals (ie, 2, 7, 30, and 90 days). The analysis included 226 683 patients from 71 articles recruited between 1981 and 2018; 5636 patients received care at TIA clinics (mean [SD] age, 65.7 [3.9] years; 2291 of 4513 [50.8%] men), 130 139 as inpatients (mean [SD] age, 78.3 [4.0] years; 49 458 of 128 745 [38.4%] men), 3605 at EDs (mean [SD] age, 68.9 [3.9] years; 1596 of 3046 [52.4%] men), and 87 303 patients received care in an unspecified setting (mean [SD] age, 70.8 [3.8] years, 43 495 of 87 303 [49.8%] men). Among the patients who were treated at a TIA clinic, the risk of subsequent stroke following a TIA or mIS was 0.3% (95% CI, 0.0%-1.2%) within 2 days, 1.0% (95% CI, 0.3%-2.0%) within 7 days, 1.3% (95% CI, 0.4%-2.6%) within 30 days, and 2.1% (95% CI, 1.4%-2.8%) within 90 days. Among the patients who were treated as inpatients, the risk of subsequent stroke was to 0.5% (95% CI, 0.1%-1.1%) within 2 days, 1.2% (95% CI, 0.4%-2.2%) within 7 days, 1.6% (95% CI, 0.6%-3.1%) within 30 days, and 2.8% (95% CI, 2.1%-3.5%) within 90 days. The risk of stroke among patients treated at TIA clinics was not significantly different from those hospitalized. Compared with the inpatient cohort, TIA clinic patients were younger and had had lower ABCD2 (age, blood pressure, clinical features, duration of TIA, diabetes) scores (inpatients with ABCD2 score >3, 1101 of 1806 [61.0%]; TIA clinic patients with ABCD2 score >3, 1933 of 3703 [52.2%]). In this systematic review and meta-analysis, the risk of subsequent stroke among patients who were evaluated in a TIA clinic was not higher than those hospitalized. Patients who received treatment in EDs without further follow-up had a higher risk of subsequent stroke. These findings suggest that TIA clinics can be an effective component of the TIA care component pathway.

Identifiants

pubmed: 34985520
pii: 2787633
doi: 10.1001/jamanetworkopen.2021.36644
pmc: PMC8733831
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2136644

Références

Stroke. 2010 Apr;41(4):661-6
pubmed: 20185781
Stroke. 2012 Nov;43(11):2936-41
pubmed: 22984016
Stroke. 2017 Jun;48(6):1678-1681
pubmed: 28438906
J Neurol. 2014 Aug;261(8):1614-21
pubmed: 24912470
Stroke. 2010 Jul;41(7):1367-70
pubmed: 20508192
Bol Asoc Med P R. 2008 Jul-Sep;100(3):11-4
pubmed: 19227709
J Vasc Interv Neurol. 2013 Feb;5(2):22-6
pubmed: 23459173
Stroke. 2009 Jun;40(6):2116-22
pubmed: 19228857
J Midlife Health. 2016 Jan-Mar;7(1):2-7
pubmed: 27134474
Stroke. 2015 May;46(5):1227-32
pubmed: 25813193
Front Neurol. 2019 Mar 27;10:294
pubmed: 30972019
Am J Emerg Med. 2020 Apr;38(4):741-745
pubmed: 31230922
Neurology. 2015 Jan 6;84(1):36-45
pubmed: 25471397
J Neurol Sci. 2011 Apr 15;303(1-2):85-9
pubmed: 21276596
Stroke. 2013 May;44(5):1244-8
pubmed: 23532014
Neurology. 2016 Apr 26;86(17):1582-9
pubmed: 27016521
Stroke. 2009 Jan;40(1):187-92
pubmed: 18988917
Acad Emerg Med. 2006 Jun;13(6):666-72
pubmed: 16609106
Lancet. 2007 Jan 27;369(9558):283-92
pubmed: 17258668
Neurologia. 2015 Jul-Aug;30(6):325-30
pubmed: 24953410
BMC Med Inform Decis Mak. 2020 Jun 18;20(1):112
pubmed: 32552700
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):38-43
pubmed: 18033799
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
BMC Neurol. 2015 May 13;15:78
pubmed: 25963672
Cerebrovasc Dis. 2007;24(2-3):231-5
pubmed: 17630483
Environ Int. 2018 Nov;120:382-387
pubmed: 30125855
Stroke. 2011 Oct;42(10):2751-7
pubmed: 21836095
Ann Emerg Med. 2011 Jan;57(1):46-51
pubmed: 20855130
Lancet. 2007 Oct 20;370(9596):1432-42
pubmed: 17928046
Pract Neurol. 2014 Feb;14(1):23-31
pubmed: 24453269
Stroke. 2017 Jun;48(6):1495-1500
pubmed: 28487336
Eur J Emerg Med. 2010 Dec;17(6):346-8
pubmed: 20164775
CMAJ. 2004 Mar 30;170(7):1105-9
pubmed: 15051694
Stroke. 2010 Nov;41(11):2601-5
pubmed: 20947856
Ann Emerg Med. 2007 Aug;50(2):109-19
pubmed: 17490788
BMC Neurol. 2019 Jan 3;19(1):2
pubmed: 30606138
JAMA Neurol. 2015 Mar;72(3):301-8
pubmed: 25580844
Stroke. 2011 Nov;42(11):3176-82
pubmed: 21921281
BMC Neurol. 2016 Feb 09;16:20
pubmed: 26857238
Neurology. 2010 Apr 27;74(17):1351-7
pubmed: 20421579
Stroke. 1984 Jul-Aug;15(4):723-5
pubmed: 6464066
J Neurol. 1991 Apr;238(2):87-90
pubmed: 1856742
J Stroke Cerebrovasc Dis. 2012 Aug;21(6):467-70
pubmed: 21388829
Ann Emerg Med. 2019 Oct;74(4):562-571
pubmed: 31326206
J Stroke Cerebrovasc Dis. 2009 Sep-Oct;18(5):367-73
pubmed: 19717021
Int Arch Med. 2013 May 01;6(1):19
pubmed: 23635082
Stroke. 2008 Feb;39(2):297-302
pubmed: 18174479
West J Emerg Med. 2018 Mar;19(2):216-223
pubmed: 29560046
Stroke. 1999 Nov;30(11):2502-11
pubmed: 10548693
Lancet. 2005 Jul 2-8;366(9479):29-36
pubmed: 15993230
BMC Neurol. 2010 Jun 21;10:50
pubmed: 20565966
Eur Neurol. 2015;74(1-2):1-7
pubmed: 26044401
J Neurol. 2009 Apr;256(4):639-44
pubmed: 19373427
Am J Emerg Med. 2010 Jan;28(1):44-8
pubmed: 20006200
Environ Int. 2019 Jan;122:168-184
pubmed: 30473382
Stroke. 2014 Jan;45(1):92-100
pubmed: 24262323
J Prim Health Care. 2017 Jun;9(2):131-135
pubmed: 29530224
Stroke. 2008 Sep;39(9):2461-6
pubmed: 18617658
J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3436-3442
pubmed: 30193811
Can J Neurol Sci. 2009 Jul;36(4):450-5
pubmed: 19650355
Front Neurol Neurosci. 2014;33:30-40
pubmed: 24157555
Neurology. 2015 Apr 14;84(15):1545-51
pubmed: 25795645
J Stroke Cerebrovasc Dis. 2015 May;24(5):1000-7
pubmed: 25813066
Clin Med (Lond). 2017 Oct;17(5):478
pubmed: 28974606
Neurology. 2004 Jun 8;62(11):2015-20
pubmed: 15184607
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Intern Med J. 2012 Aug;42(8):913-8
pubmed: 21790923
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):99-105
pubmed: 23164482
J Clin Neurosci. 2013 Jul;20(7):988-92
pubmed: 23712054
Stroke. 2010 May;41(5):844-50
pubmed: 20299667
Lancet Neurol. 2007 Nov;6(11):953-60
pubmed: 17928270
Neurocrit Care. 2009;10(2):204-8
pubmed: 18850077
J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):356-61
pubmed: 23172867
Stroke. 2014 Nov;45(11):3214-8
pubmed: 25256181
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
CMAJ. 2004 Mar 30;170(7):1099-104
pubmed: 15051693
Arch Neurol. 2008 Jun;65(6):733-7
pubmed: 18541793
CJEM. 2016 Sep;18(5):331-9
pubmed: 26879765
J Emerg Med. 2013 May;44(5):970-5
pubmed: 23478183
Stroke. 2011 Aug;42(8):2186-90
pubmed: 21680907
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):673-8
pubmed: 21482142
Cerebrovasc Dis. 2017;43(1-2):25-30
pubmed: 27750222
Stroke. 2004 Aug;35(8):1842-6
pubmed: 15192239
eNeurologicalSci. 2019 May 16;15:100193
pubmed: 31193470
Stroke. 2014 Feb;45(2):418-25
pubmed: 24335223
Stroke. 2009 Jan;40(1):181-6
pubmed: 18948609
Stroke. 2011 Jul;42(7):1839-43
pubmed: 21617143
Cerebrovasc Dis. 2014;37(5):330-5
pubmed: 24903456
Eur J Emerg Med. 2016 Feb;23(1):19-23
pubmed: 24849610
Stroke. 1989 Feb;20(2):300-1
pubmed: 2919420
Int J Stroke. 2018 Jun;13(4):420-443
pubmed: 29171361
Cerebrovasc Dis. 2008;26(6):630-5
pubmed: 18984948
Stroke. 2012 Dec;43(12):3395-8
pubmed: 23138440
Int J Stroke. 2015 Apr;10(3):343-7
pubmed: 25367837
Int J Stroke. 2019 Dec;14(9):871-877
pubmed: 30917776
Stroke. 2005 Apr;36(4):720-3
pubmed: 15731465
Eur J Neurol. 2012 Jan;19(1):55-61
pubmed: 21554497
J Vasc Interv Neurol. 2017 Jun;9(4):49-53
pubmed: 28702120
Int J Stroke. 2020 Apr;15(3):278-288
pubmed: 30734663
Eur J Neurol. 2011 Nov;18(11):1285-90
pubmed: 21645177
Lancet Neurol. 2010 Nov;9(11):1060-9
pubmed: 20934388
JAMA. 2007 Dec 26;298(24):2877-85
pubmed: 18159057
Stroke. 1982 Jan-Feb;13(1):32-5
pubmed: 7064176
Front Neurol. 2018 Oct 26;9:914
pubmed: 30416483
J Am Heart Assoc. 2016 Sep 24;5(9):
pubmed: 27664805
Stroke. 1996 Dec;27(12):2225-9
pubmed: 8969785
Cerebrovasc Dis. 2012;33(2):150-8
pubmed: 22178747
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):291-295
pubmed: 29108805
Ann Emerg Med. 2010 Feb;55(2):201-210.e5
pubmed: 19556026
QJM. 2010 Sep;103(9):679-85
pubmed: 20601651
J Neurol Sci. 2014 Jan 15;336(1-2):83-6
pubmed: 24209902
Acad Emerg Med. 2008 Feb;15(2):171-6
pubmed: 18275447
Neurology. 2015 Jul 28;85(4):373-80
pubmed: 26136519
Stroke. 2014 Oct;45(10):2918-23
pubmed: 25169950
JAMA Neurol. 2021 Jan 1;78(1):77-87
pubmed: 33044505
Stroke. 2007 Jun;38(6):1881-5
pubmed: 17431209
Neurology. 2016 Mar 8;86(10):947-53
pubmed: 26802089

Auteurs

Shima Shahjouei (S)

Neurology Department, Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania.

Jiang Li (J)

Department of Molecular and Functional Genomics, Geisinger Health System, Danville, Pennsylvania.

Eric Koza (E)

Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania.

Vida Abedi (V)

Department of Molecular and Functional Genomics, Geisinger Health System, Danville, Pennsylvania.
Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia.

Alireza Vafaei Sadr (AV)

Department de Physique Theorique and Center for Astroparticle Physics, University Geneva, Geneva, Switzerland.

Qiushi Chen (Q)

Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park.

Ashkan Mowla (A)

Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles.

Paul Griffin (P)

Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park.

Annemarei Ranta (A)

Department of Neurology, Wellington Hospital, Wellington, New Zealand.
Department of Medicine, University of Otago, Wellington, New Zealand.

Ramin Zand (R)

Neurology Department, Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH